(Q46029893)

18 December 2017

title

The European CRT Survey: 1 year (9-15 months) follow-up results. (English)

1 reference

18 December 2017

Nigussie Bogale

1

0 references

Cecilia Linde

Cecilia Linde

5

0 references

Marco Metra

Marco Metra

13

0 references

Josep Brugada

Josep Brugada

4

0 references

Geneviève Derumeaux

14

Geneviève Derumeaux

1 reference

18 December 2017

6

Angelo Auricchio

1 reference

PubMed ID

22179034

18 December 2017

Dirk J van Veldhuisen

7

Dirk J van Veldhuisen

1 reference

18 December 2017

Kenneth Dickstein

17

Kenneth Dickstein

1 reference

18 December 2017

author name string

Silvia Priori

2

1 reference

18 December 2017

John G F Cleland

3

1 reference

18 December 2017

Tobias Limbourg

8

1 reference

18 December 2017

Anselm Gitt

9

1 reference

18 December 2017

Daniel Gras

10

1 reference

18 December 2017

Christoph Stellbrink

11

1 reference

18 December 2017

Maurizio Gasparini

12

1 reference

18 December 2017

Fredrik Gadler

15

1 reference

18 December 2017

Laszlo Buga

16

1 reference

18 December 2017

Scientific Committee, National Coordinators, and Investigators

18

1 reference

18 December 2017

publication date

1 January 2012

1 reference

18 December 2017

European Journal of Heart Failure

published in

1 reference

18 December 2017

volume

14

1 reference

18 December 2017

issue

1

1 reference

18 December 2017

page(s)

61-73

1 reference

18 December 2017

Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay.

cites work

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR158

Cardiac resynchronization in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR158

Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR158

The effect of cardiac resynchronization on morbidity and mortality in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR158

Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR158

Cardiac-resynchronization therapy for the prevention of heart-failure events.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR158

Cardiac-resynchronization therapy for mild-to-moderate heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR158

Guidelines for cardiac pacing and cardiac resynchronization therapy. The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR158

ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Gui

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR158

Implementation of device therapy (cardiac resynchronization therapy and implantable cardioverter defibrillator) for patients with heart failure in Europe: changes from 2004 to 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR158

Tracing the European course of cardiac resynchronization therapy from 2006 to 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR158

Trial and error. How to avoid commonly encountered limitations of published clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR158

The role of cardiac registries in evidence-based medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR158

Clinical trials and registries in cardiovascular disease: competitive or complementary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR158

Impact of study design on outcome after endovascular abdominal aortic aneurysm repair. A comparison between the randomized controlled DREAM-trial and the observational EUROSTAR-registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR158

The European cardiac resynchronization therapy survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR158

European cardiac resynchronization therapy survey: rationale and design

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR158

The European Cardiac Resynchronization Therapy Survey: comparison of outcomes between de novo cardiac resynchronization therapy implantations and upgrades

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR158

The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR158

Long-term survival of patients with heart failure and ventricular conduction delay treated with cardiac resynchronization therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR158

Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR158

Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR158

Long-term survival in patients undergoing cardiac resynchronization therapy: the importance of performing atrio-ventricular junction ablation in patients with permanent atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR158

Cardiac resynchronization therapy in patients undergoing atrioventricular junction ablation for permanent atrial fibrillation: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR158

Heart failure decompensation and all-cause mortality in relation to percent biventricular pacing in patients with heart failure: is a goal of 100% biventricular pacing necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR158

Cardiac resynchronization therapy in patients with right bundle branch block: analysis of pooled data from the MIRACLE and Contak CD trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR158

The effects of aetiology on outcome in patients treated with cardiac resynchronization therapy in the CARE-HF trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR158

Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase].

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR158

2010 Focused Update of ESC Guidelines on device therapy in heart failure: An update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy De

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR158

21 January 2018

Identifiers

DOI

10.1093/EURJHF/HFR158

1 reference

18 December 2017

PubMed ID

22179034

1 reference

18 December 2017